KLF4 and sarcoma: Kaplan–Meier survival analysis shows that in sarcoma, the overall survival rate of patients with high mTOR expression is lower than that of patients with low mTOR expression, and the effect of KLF4 is really just the opposite (Figure 1(d,h)).